CARIS CONFIRM
Intent to Use
TM99711075
Kind: intent_to_use
Mar 19, 2026
Abstract
Medical testing for diagnostic or treatment purposes in the field of oncology, namely, detection of tumor-derived genetic variants and minimal residual disease in circulating tumor DNA (ctDNA); Providing medical analysis and detection of tumor-derived genetic variants and minimal residual disease in circulating tumor DNA (ctDNA) for scientific and medical research purposes
Filing Date
2026-03-18